Increased vascular smooth muscle cell stiffness: a novel mechanism for aortic stiffness in hypertension

Nancy L Sehgel1, Yi Zhu, Zhe Sun

  • 1Department of Cell Biology and Molecular Medicine, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey;

Insights

Hypertension increases vascular stiffness due to changes in vascular smooth muscle cells, not just the extracellular matrix. This finding offers new therapeutic targets for hypertension and vascular stiffness.

Area of Science:

  • Cardiovascular Science
  • Biomedical Engineering
  • Cellular Mechanics

Background:

  • Vascular stiffness is a key factor in hypertension and its complications like atherosclerosis.
  • Current understanding attributes vascular stiffness primarily to extracellular matrix and endothelial factors.
  • The role of intrinsic vascular smooth muscle cell (VSMC) mechanical properties remains under-explored.

Purpose of the Study:

  • To investigate the hypothesis that increased large-artery stiffness in hypertension involves intrinsic VSMC mechanical properties.
  • To explore the dynamic component of cellular elastic stiffness in hypertension.
  • To identify potential therapeutic targets within VSMCs for managing hypertension-related vascular stiffness.

Main Methods:

  • Utilized spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) normotensive controls.
  • Employed an engineered aortic tissue model to assess VSMC stiffness.
  • Applied atomic force microscopy (AFM) nanoindentation for precise measurement of cellular elastic stiffness.
  • Investigated the effect of VSMC cytoskeletal protein inhibitors on cellular stiffness.

Main Results:

  • Confirmed increased aortic stiffness and arterial pressure in SHR compared to WKY rats.
  • Demonstrated significantly increased elastic stiffness in aortic VSMCs from SHR versus WKY rats.
  • Observed altered temporal oscillations in VSMC stiffness in hypertensive rats, indicating a dynamic change.
  • Showed that inhibitors of VSMC cytoskeletal proteins effectively reduced cellular stiffness in both hypertensive and control groups.

Conclusions:

  • This study provides the first evidence that individual VSMC stiffness contributes to overall vascular stiffness in hypertension.
  • Altered intrinsic mechanical properties of VSMCs represent a novel mechanism underlying hypertension-induced vascular stiffness.
  • These findings suggest that targeting VSMC stiffness may offer new therapeutic strategies for hypertension and associated vascular complications.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.